Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Analysis of HLA gene expression in patients with dMMR/MSI-H colorectal carcinoma resistant to immune checkpoint inhibitors.
Authors
Heinz-Josef Lenz
Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA;
Heinz-Josef Lenz , Theodore Nicolaides , Andrew Elliott , Richard M. Goldberg , John Marshall , Emil Lou , Anthony Frank Shields , Davendra Sohal , Benjamin Adam Weinberg , David Spetzler , Jim Abraham , Joanne Xiu , Wolfgang Michael Korn
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 202)
DOI
10.1200/JCO.2023.41.4_suppl.202
Abstract #
202
Poster Bd #
L4
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Preoperative nivolumab plus SOX in patients with locally advanced gastric or gastro-esophageal junction cancer: A phase 2, single-arm trial.
First Author: Xiangdong Cheng
Poster
2024 ASCO Genitourinary Cancers Symposium
Preclinical testing of a novel PD-L1 inhibitor for the treatment of renal cell carcinoma.
First Author: Michelle Hsu
Poster
2023 ASCO Annual Meeting
Using machine learning to characterize lung cancer microenvironment and the development of a model to predict the presence of similar microenvironment in other cancers.
First Author: Ahmad Charifa
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Characterizing colorectal cancer (CRC) carriers of the recessive MUTYH founders (G396D/Y179C) and the low-penetrance APC founder APC-I1307K mutation.
First Author: Dong Kim